About Foundation Medicine
Foundation Medicine is a company based in Cambridge (United States) founded in 2010 by Todd Golub, Eric Lander, and Matthew Meyerson was acquired by Roche in January 2015.. Foundation Medicine has raised $96.5 million across 4 funding rounds from investors including Roche, Kleiner Perkins and The Gates Notes. Foundation Medicine has completed 1 acquisition, including Lexent Bio. Foundation Medicine offers products and services including FoundationOne CDx, FoundationOne Liquid CDx, FoundationOne RNA, and FoundationOne Heme. Foundation Medicine operates in a competitive market with competitors including Guardant Health, MedGenome, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Cambridge, United States
- Founders Todd Golub, Eric Lander, Matthew Meyerson
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Foundation Medicine, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Foundation Medicine
Foundation Medicine offers a comprehensive portfolio of products and services, including FoundationOne CDx, FoundationOne Liquid CDx, FoundationOne RNA, and FoundationOne Heme. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Test for analyzing tumor genes in advanced cancer patients
Test using cell-free DNA for cancer mutation detection
Test for detecting RNA fusions in cancer samples
Test for genomic profiling in blood cancers
Unlock access to complete
Leadership Team
85 people
Software Development Team
52 people
Sales and Marketing
34 people
Senior Team
32 people
Operations Team
27 people
Human Resources and Administration
20 people
Data Analysis and Operations Team
16 people
Legal and Compliance
15 people
Unlock access to complete
Funding Insights of Foundation Medicine
Foundation Medicine has successfully raised a total of $96.5M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $13.5 million completed in January 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $13.5M
-
First Round
First Round
(15 Apr 2010)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2013 | Amount | Series B - Foundation Medicine | Valuation |
investors |
|
| Sep, 2012 | Amount | Series B - Foundation Medicine | Valuation | Casdin Capital , Deerfield | |
| Aug, 2011 | Amount | Series A - Foundation Medicine | Valuation | Google Ventures , Kleiner Perkins |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Foundation Medicine
Foundation Medicine has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Roche, Kleiner Perkins and The Gates Notes. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investing in Life Sciences sectors like Healthcare and Biotechnology.
|
Founded Year | Domain | Location | |
|
Venture capital funding is provided to early-stage life science companies.
|
Founded Year | Domain | Location | |
|
Healthcare ecosystem is supported through investment and innovation by Deerfield.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Foundation Medicine
Foundation Medicine has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Lexent Bio. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bioinformatics and genomic science are provided for cancer diagnosis.
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Foundation Medicine
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Foundation Medicine Comparisons
Competitors of Foundation Medicine
Foundation Medicine operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, MedGenome, ArcherDX, Natera and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
DNA sequencing, bioinformatics, and multiomics services are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Foundation Medicine
When was Foundation Medicine founded?
Foundation Medicine was founded in 2010.
Where is Foundation Medicine located?
Foundation Medicine is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Foundation Medicine a funded company?
Foundation Medicine is a funded company, having raised a total of $96.5M across 4 funding rounds to date. The company's 1st funding round was a Series A of $33.5M, raised on Apr 15, 2010.
What does Foundation Medicine do?
Provider of genomics-based diagnostics test for cancer. The companys clinical assays, FoundationOne for solid tumors, FoundationOne Heme for hematologic malignancies and sarcomas, and the liquid biopsy test FoundationACT provide a complete genomic profile of cancers, which oncologists can use to inform their treatment decisions. In addition, all tests provide an estimate of tumor mutational burden that enables oncologists to predict immunotherapy response as well.
Who are the top competitors of Foundation Medicine?
Foundation Medicine's top competitors include Guardant Health, Strand Life Sciences and MedGenome.
What products or services does Foundation Medicine offer?
Foundation Medicine offers FoundationOne CDx, FoundationOne Liquid CDx, FoundationOne RNA, and FoundationOne Heme.
How many acquisitions has Foundation Medicine made?
Foundation Medicine has made 1 acquisition, including Lexent Bio.
Who are Foundation Medicine's investors?
Foundation Medicine has 9 investors. Key investors include Roche, Kleiner Perkins, The Gates Notes, Casdin Capital, and Third Rock Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.